Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Transition Bio provides condensate technology for drug discovery and diagnostics.
VieCure built an engine to turn data into knowledge and take the world’s best thinking to clinicians and patients in real time.
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
QbDVision is a biopharma company that offers a platform designed specifically for biotech products, teams, and processes.
EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
OPT Industries is an advanced digital manufacturing suite, specializing in designing and mass-producing consumer products.
Inflammatix develops rapid immune system diagnostics to improve patient care and public health.
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Scitara offers a cloud-based connectivity platform that transforms integration between instruments and lab informatics applications.
Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.
Isolere Bio is a Healthcare Company provides manufacturing solutions,facilitate therapeutic developments.
Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.
Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.
Story Health helps specialists to understand medical situations and make clinical decisions that are through virtual protocols.
Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.
Vizgen provides spatial multi-omics platforms enabling researchers to reveal cellular insights through spatial transcriptomics proteomics.
Outcomes4Me develops direct-to-patient AI-driven platform designed to assist cancer patients in managing their care.
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Northpond Ventures has invested in 47 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Northpond Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Health Diagnostics. The firm invests across 23 different industry categories.
Among tracked funding rounds, Telesis Bio received $74.2M in a Post-IPO Equity round. Northpond Ventures's total known invested capital is $1.3B.
Northpond Ventures's average investment size is $27.3M across its portfolio of 47 companies.
Recent Northpond Ventures portfolio additions include Transition Bio, VieCure, Elephas, QbDVision, EnPlusOne Biosciences. These companies were founded in 2020 or later.